Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Lawsuits Over Tepezza and Hearing Loss Will Be Prepared For First Jury Trial in March 2026 A series of four Tepezza hearing loss lawsuits will go to trial between March 9, 2026 and August 24, 2026, to help determine the average payout juries may award and promote settlement negotiations June 5, 2024 Irvin Jackson Add Your Comments Lawyers involved in federal Tepezza hearing loss litigation have submitted proposed schedules leading up to the first bellwether trials, which will help gauge how juries may respond to certain evidence and testimony that will be repeated throughout hundreds of claims. While the parties still have a number of disagreements regarding deadlines leading up to the start of the first trial, both sides have agreed that the process should culminate with a series of four cases going before juries between March 2026 and August 2026. Each of the claims involve similar allegations that Horizon Therapeutics failed to adequately warn users about the link between hearing loss and Tepezza (teprotumumab-trbw), which is a new-generation biologic treatment marketed for thyroid eye disease or bulging eyes. Although Tepezza infusions were originally intended as a niche treatment, with only a limited market, during the second year the drug was on the market in the United States sales doubled to $1.66 billion, and critics have expressed concern that Tepezza was aggressively marketed without adequately disclosing that users may experience permanent and irreversible hearing loss. Tepezza Lawsuits Did You or a Loved One Receive a Tepezza Injection? Side effects of Tepezza may cause permanent hearing problems. Lawsuits are being pursued over the drug maker’s failure to warn about the risk. Find out if qualify for a settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Tepezza Lawsuits Did You or a Loved One Receive a Tepezza Injection? Side effects of Tepezza may cause permanent hearing problems. Lawsuits are being pursued over the drug maker’s failure to warn about the risk. Find out if qualify for a settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in complaints filed in federal courts nationwide, a Tepezza MDL (multidistrict litigation) was established last year, centralizing the lawsuits before U.S. District Judge Thomas Durkin in the Northern District of Illinois for coordinated discovery and pretrial proceedings. As part of the coordinated management of the litigation, Judge Durkin has established a “bellwether” program, where a group of 12 representative cases have been selected to go through case-specific discovery in preparation for early trial dates, which will help the parties gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout various cases in the litigation. Plaintiffs previously selected four bellwether lawsuits over Tepezza and hearing loss, and Horizon Therapeutics submitted it’s list of four claim on May 30, 2024. The last four cases will be generated randomly and submitted to the court by June 6, 2024. Tepezza Lawsuit Bellwether Trial Dates Earlier this month, Judge Durkin held oral arguments on the Tepezza bellwether trial schedule, determining that the first bellwether trial will begin on March 9, 2026. It will be the first of four of such trials, with the second beginning on May 4, 2026, a third trial scheduled for June 29 of that year, and the fourth to begin on August 24, 2026. The parties submitted a joint proposed case management order (PDF) on May 10, and were able to reach agreement on most, but not all, dates in the schedule. The parties set a date of December 20, 2024 for the close of fact discovery for the 12 selected cases. However, the parties disagree on the deadline for the close of corporate fact discovery, and the page length and format of any motions to dismiss cases selected for potential bellwether trials. On May 13, the court issued a Notice of Docket Entry (PDF) indicating the parties should meet and confer to attempt to come to an agreement on the remaining scheduling issues in dispute by June 11. They will then submit a written report either on a final joint scheduling order, or they can present their respective proposals to the court. However, the notice indicates the parties should first try to reach an agreement beforehand. June 2024 Tepezza Settlement Update While the outcome of these early bellwether trials will not have any binding impact on other claims presented in the litigation, the average Tepezza lawsuit payouts awarded by juries are likely to have a large impact on settlement negotiations between the parties. The bellwether selections are intended to involve claims will be representative of the larger litigation, helping the parties weigh the relative strengths and weaknesses of the allegations that users may have avoided Tepezza hearing problems if the drug maker had disclosed information about the risk, and instructed doctors to obtain hearing tests before and during treatments. In July 2023, the U.S. Food and Drug Administration (FDA) released a new version of the Tepezza prescribing information guide, which now adds many of the same hearing loss warnings plaintiffs indicate should have been included when the drug was first introduced. The new Tepezza label update now discloses that users have been left with severe and permanent hearing loss. It also indicates doctors should assess patients’ hearing before, during, and after Tepezza infusions, to avoid users experiencing permanent ear damage. Following the bellwether trials, if the parties fail to reach Tepezza hearing loss settlements or another resolution for the litigation, Judge Durkin may begin remanding individual cases to U.S. District Courts nationwide for separate trial dates in the coming years. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior legal and investigative journalist with more than 30 years of experience covering complex issues at the intersection of law, politics, and environmental policy. He began his reporting career in 1991 after graduating from Wayne. Tags: Hearing Damage, Hearing Loss, Horizon Therapeutics, Tepezza, Thyroid Eye Disease, Tinnitus More Tepezza Lawsuit Stories First Tepezza Hearing Loss Lawsuit Set To Go Before Jury in June 2026 July 21, 2025 Tepezza Tinnitus and Hearing Loss Lawsuits Move Into Expert Discovery Phase June 11, 2025 Tepezza Lawyers Meet With MDL Judge To Review Status of Hearing Loss Lawsuits Today March 31, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Strattice Mesh Lawsuit Scheduled for First Federal Bellwether Trial (Posted: yesterday) A U.S. federal magistrate judge will meet with parties this Wednesday to discuss preparation for the first Strattice hernia mesh bellwether trial that is scheduled to begin in February. MORE ABOUT: HERNIA MESH LAWSUITCovidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (05/21/2025)Second Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025) Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (Posted: 2 days ago) Hologic, Inc. faces a BioZorb tissue marker lawsuit filed by two Montana women who say the implants failed to absorb properly into their bodies. MORE ABOUT: BIOZORB LAWSUITLawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025) Judge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (Posted: 2 days ago) The first Cartiva toe implant trial has been delayed until August 2026, with parties ordered to engage in settlement negotiations. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (03/31/2025)
Strattice Mesh Lawsuit Scheduled for First Federal Bellwether Trial (Posted: yesterday) A U.S. federal magistrate judge will meet with parties this Wednesday to discuss preparation for the first Strattice hernia mesh bellwether trial that is scheduled to begin in February. MORE ABOUT: HERNIA MESH LAWSUITCovidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (05/21/2025)Second Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025)
Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (Posted: 2 days ago) Hologic, Inc. faces a BioZorb tissue marker lawsuit filed by two Montana women who say the implants failed to absorb properly into their bodies. MORE ABOUT: BIOZORB LAWSUITLawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)
Judge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (Posted: 2 days ago) The first Cartiva toe implant trial has been delayed until August 2026, with parties ordered to engage in settlement negotiations. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (03/31/2025)